XML 28 R13.htm IDEA: XBRL DOCUMENT

7. Outstanding Warrants

12 Months Ended

Dec. 31, 2016

Text Block [Abstract]

7. Outstanding Warrants

During the years ended December 31, 2016 and 2015, the Company granted 227 thousand and 229 thousand common stock warrants, for the extension of certain Notes. The accredited investors received 2 year warrants exercisable at $0.01 per share as part of note agreements. In 2015, the Company also granted 110 thousand common stock warrants outside the Company plans to certain employees with 1/12^th vesting every three months over 3 years and to Directors with immediate vesting. These warrants have a 10 year term and are exercisable at $2.59 per share as part of the warrant agreement.

The weighted average fair value calculations for warrants granted are based on the following weighted average assumptions:

For the years ended December 31, 2016 and 2015, Note investors exercised 227 thousand and 229 thousand warrant shares at exercise prices of $0.01 per share, respectively.

A summary of historical warrant activity for the years ended December 31, 2016 and 2015 follows:

Description		For the year ended December 31
		2016				2015
Dividend-yield			0	%			0	%
Risk-free interest rate			0.81	%			1.1	%
Expected volatility			71.8	%			80.0	%
Expected life (years)			2				3.62
Market value per share on grant date		$	2.56			$	4.06
Exercise price per share		$	0.01			$	0.85
Fair value per share on grant date		$	2.55			$	3.85

		Warrants Outstanding & Exercisable				Weighted - Average Exercise Price				Average Remaining Term in Years
Outstanding December 31, 2014			351			$	3.05				2.69
Granted			339				0.85
Exercised			(272	)			0.21
Expired			(50	)			1.30
Outstanding December 31, 2015			368			$	3.36				4.61
Exercised			(233	)			0.01
Granted			227				0.01
Expired			(18	)			0.01
Outstanding December 31, 2016			344			$	3.33				3.88

40 thousand of the above outstanding warrants are not vested and exercisable as of December 31, 2016. As of December 31, 2016, the Company had $77 thousand of total unrecognized compensation expense related to warrants which the Company will amortize over the 1.94 years of weighted remaining term.

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details